MedTrace Logo

Fluorescence-guided Resection in Breast Cancer

NCT01110954 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2017-04-04

No results posted yet for this study

Summary

This is an explorative phase II study to investigate the suitability of PD L 506 in the specific intra-operative detection of breast tumour tissue.

Conditions

  • Breast Tumour

Interventions

DRUG

PD L 506

Two different doses will be compared

Sponsors & Collaborators

  • photonamic GmbH & Co. KG

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-07-19
Completion
2012-12-20

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01110954 on ClinicalTrials.gov